OBJECTIVE  To analyze the current status and development trends of clinical contexts, models and decision aids in shared decision-making(SDM) in clinical practice in China, and to provide evidence for optimizing practical pathways based on medication decision-making and rational medication use.

METHODS  A scoping review was conducted by systematically searching databases including China National Knowledge Infrastructure(CNKI), SinoMed, stc., and applying standardized criteria for literature screening and data extraction. Descriptive analysis focused on research characteristics, application scenarios, and tool utilization, with an emphasis on the role of SDM in medication decision-making.

RESULTS  The initial examination yielded 1606 documents, and 159 were finally included. The study revealed a growing trend in SDM research in China, with clinical applications concentrated in chronic diseases(e.g., diabetes) and oncology. SDM models integrated theory and practice, with in-depth exploration of decision aids and participant roles. Notably, SDM demonstrated significant potential in improving medication adherence and rational drug use, particularly in diabetes and psychiatric care.

CONCLUSION  SDM in China is transitioning from theoretical exploration to clinical implementation. Future efforts should address diverse perspectives and clinical scenarios, extend SDM to medication decision-making and rational use, prioritize multidisciplinary collaboration and innovative tools, and strengthen policy frameworks to integrate patient preferences into clinical practice. This will contribute to advancing SDM research and enhancing therapeutic outcomes in China.